| Insider | Role | Shares | Value | Buys | Sells |
|---|---|---|---|---|---|
| Date | Ticker | Insider | Role | Type | Shares | Price | Value | Chg% | SEC |
|---|---|---|---|---|---|---|---|---|---|
| Insider | Role | Shares | Value | Buys | Sells |
|---|---|---|---|---|---|
| Date | Ticker | Insider | Role | Type | Shares | Price | Value | Chg% | SEC |
|---|---|---|---|---|---|---|---|---|---|
Hcw Biologics Inc. (HCWB) has 3 insiders with recent SEC Form 4 filings, including 18 buys and 0 sells. HCWB is classified in the Biotechnology industry within the Health Care sector.
| Role | Insider | Shares | Value | 30d |
|---|---|---|---|---|
| CEO | 501.9K | $165.0K | - | |
| Dir | 25.5K | $8.4K | - | |
| Dir | 4.1K | $1.3K | - |
Buys and sells only
| Date | Insider | Role | Type | Shares | Price | Value | Chg% | 3M | 12M | SEC |
|---|---|---|---|---|---|---|---|---|---|---|
| Aug 31, 2022 | Byam Rebecca | Chief Financial Officer | Buy | 17,200 | $2.55 | $43,913.28 | +3.2% | -16.2% | -29.5% | |
| Aug 29, 2022 | Byam Rebecca | Chief Financial Officer | Buy | 20,000 | $2.55 | $51,020.00 | +4.0% | -14.4% | -24.0% | |
| Aug 25, 2022 | Byam Rebecca | Chief Financial Officer | Buy | 90,300 | $2.54 | $229,747.08 | +25.0% | -15.9% | -22.7% | |
| Jun 14, 2022 | Byam Rebecca | Chief Financial Officer | Buy | 66,452 | $2.42 | $160,798.46 | +35.8% | -2.2% | -21.9% | |
| Jun 10, 2022 | Wong Hing C | Chief Executive Officer | Buy | 1,520 | $2.19 | $3,325.76 | - | +23.7% | -6.0% | |
| Jun 10, 2022 | Winer Gary M60 | Director | Buy | 3,500 | $2.19 | $7,672.65 | +11.1% | +23.7% | -6.0% | |
| Jun 9, 2022 | Wong Hing C | Chief Executive Officer | Buy | 3,000 | $2.27 | $6,800.00 | - | +17.2% | -8.6% | |
| Jun 7, 2022 | Winer Gary M60 | Director | Buy | 2,000 | $2.11 | $4,227.30 | +12.5% | +14.5% | -8.4% | |
| Jun 2, 2022 | Greene Rick S. | Director | Buy | 4,800 | $2.09 | $10,040.64 | +132.9% | +17.2% | -27.9% | |
| Dec 6, 2021 | Jiao Jin-An | VP Of Development | Buy | 10,000 | $2.42 | $24,150.00 | +48.6% | -12.1% | -17.4% |